BAM
Burgundy Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.5M | Buy |
280,170
+277,450
| +10,200% | +$42.1M | 0.41% | 73 |
|
|
2025
Q1 | $409K | Buy |
2,720
+1,416
| +109% | +$213K | ﹤0.01% | 104 |
|
|
2024
Q4 | $241K | Hold |
1,304
| – | – | ﹤0.01% | 102 |
|
|
2024
Q3 | $257K | Buy |
1,304
+231
| +22% | +$45.5K | ﹤0.01% | 104 |
|
|
2024
Q2 | $222K | Hold |
1,073
| – | – | ﹤0.01% | 103 |
|
|
2024
Q1 | $291K | Hold |
1,073
| – | – | ﹤0.01% | 100 |
|
|
2023
Q4 | $254K | Buy |
+1,073
| New | +$254K | ﹤0.01% | 103 |
|